Biotech Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia August 1, 2022
Biotech Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022 August 1, 2022
Biotech European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries August 1, 2022
Biotech Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update August 1, 2022
Biotech Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022 August 1, 2022
Biotech Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma August 1, 2022
Biotech Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call August 1, 2022
Biotech Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th August 1, 2022